ARTICLE | Clinical News
Amphetamine XR oral suspension regulatory udpate
November 22, 2016 11:36 PM UTC
Neos submitted an NDA to FDA for NT-0201 to treat ADHD. The product is an oral suspension extended-release amphetamine polistirex using Neos’ dynamic time release suspension (DTRS) technology....
BCIQ Company Profiles